Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 19 peer-reviewed journal articles Updated
Cardiology

Recognizing Changes and Red Flags

At a Glance

Autoimmune myocarditis can worsen quickly, and dangerous rhythm or heart-pumping problems may occur even when the ejection fraction is normal. Fainting, severe breathlessness, shock symptoms, severe chest pressure, or new heart-rate changes require immediate emergency care.

Autoimmune myocarditis is a “great mimicker.” Because the heart is involved in everything from your circulation to your electrical rhythm, symptoms can range from subtle fatigue to sudden, severe chest pain [1][2]. Understanding this spectrum is vital because how you feel today may not always reflect the amount of inflammation occurring in your heart muscle [3].

The Spectrum of Symptoms

Symptoms often depend on whether the inflammation is “smoldering” or “fulminant.”

  • Subclinical/Smoldering: You might feel nothing at all, or only mild fatigue and nausea [1]. In these cases, the condition is often caught by accident through a blood test (like troponin) or an ECG (electrocardiogram) [4].
  • Overt/Acute: This is more obvious and often feels like a heart attack, with chest pain, palpitations, and shortness of breath (dyspnea) [2][5].
  • Fulminant: This is a medical emergency where the heart’s pumping or electrical system fails rapidly, leading to cardiogenic shock (when the heart can’t pump enough blood for the body’s needs) [2][6].

Emergency Red Flags

Because myocarditis can worsen quickly, you should never assume that mild or new symptoms will just go away with rest. Always follow your care team’s individualized triage plan and promptly report any changes in how you feel. However, certain signs indicate your heart is severely struggling to maintain its rhythm or blood flow.

Call 911 or go to the nearest Emergency Department immediately if you experience:

  • Syncope or Near-Syncope: Fainting, “blacking out,” or feeling like you are about to pass out. This can be a sign of dangerous arrhythmias or complete heart block [7][8].
  • Signs of Shock: Feeling suddenly cold, clammy, or confused, or having a very pale complexion [2][6].
  • Severe Shortness of Breath: Gasping for air even while sitting still or lying flat [2][9].
  • Electrical Instability: A heart rate that is extremely slow (bradycardia) or a persistent, racing “thumping” heart that won’t stop and is accompanied by dizziness [10][11].
  • Sudden Chest Pressure: Intense “elephant on the chest” pain or pressure that does not go away [2].
  • Neuromuscular Symptoms (For ICI Patients): New drooping eyelids, double vision, trouble swallowing, neck weakness, or breathing weakness, which can signal overlapping muscle or nerve inflammation [12].

When to Seek Urgent (Same-Day) Care

If you are stable but notice new changes, contact your cardiology team that same day. Do not wait for your next scheduled appointment for:

  • New Swelling: Rapidly worsening swelling in your legs, ankles, or feet (edema) [9][13].
  • Significant Fatigue: A sudden drop in your ability to do things you could do yesterday, like walking to the mailbox [13].
  • Worsening Palpitations: Frequent “skipped beats” or racing heart that is new for you [2].
  • Signs of Infection: New fever, especially if taking immunosuppressive medications.

The “Normal” Echo Misconception

A common source of confusion for patients is the Ejection Fraction (EF). This is a percentage measured on an echocardiogram (ultrasound) that shows how much blood your heart pumps out with each beat. A “normal” EF is usually 50–70%.

It is critical to know that a normal ejection fraction does NOT mean you are out of danger [7][14].

  • Preserved LVEF: Even if your heart is still pumping a normal volume of blood, it may be struggling with diastolic dysfunction (difficulty relaxing) or impaired strain (where the heart muscle fibers are not contracting efficiently) [15][16].
  • Electrical vs. Mechanical: Your heart’s “pump” (the EF) can look normal while its “electrical wiring” is being damaged by inflammation. Life-threatening rhythm issues like heart block can occur even when the EF is 60% or higher [7][17].

Your doctor will use complementary monitoring interpreted together—such as troponin trends, natriuretic peptides (like NT-proBNP, which indicate heart stretch/stress), ECG changes, and specialized imaging like Global Longitudinal Strain (GLS), which measures myocardial deformation—to guide your care [18][19]. No single normal test excludes clinically important myocarditis or arrhythmia.

Common questions in this guide

Which symptoms of autoimmune myocarditis mean I should call 911?
Call 911 or go to an emergency department for fainting or near-fainting, severe breathlessness at rest or while lying flat, severe chest pressure, signs of shock such as cold clammy skin or confusion, or a very slow or persistently racing heartbeat with dizziness. If you are receiving an immune checkpoint inhibitor and develop new drooping eyelids, double vision, trouble swallowing, neck weakness, or breathing weakness, seek emergency care as well.
When should I contact my cardiology team about myocarditis?
Contact your cardiology team the same day for new or rapidly worsening swelling in your legs, ankles, or feet; a sudden drop in your ability to do routine activities; new frequent skipped beats or racing; or a new fever, particularly if you take immunosuppressive medicines. Do not wait for a scheduled appointment if these changes are new.
Can autoimmune myocarditis be dangerous even when my ejection fraction is normal?
Yes. A normal ejection fraction, often about 50–70%, shows that the heart is pumping a usual percentage of blood, but it does not rule out inflammation, difficulty relaxing, reduced contraction efficiency, or electrical problems such as heart block.
What tests are used to monitor autoimmune myocarditis?
Clinicians may follow troponin and NT-proBNP blood-test trends, ECG changes, echocardiogram findings, and global longitudinal strain, which measures how the heart muscle contracts. These results are interpreted together because one normal test does not rule out clinically important myocarditis or an abnormal heart rhythm.
Can autoimmune myocarditis cause only mild or no symptoms?
Yes. Some people have no symptoms or only mild fatigue and nausea, and myocarditis may be found through a blood test such as troponin or an ECG. Symptoms can also become more obvious, with chest pain, palpitations, and shortness of breath, or progress rapidly in severe cases.
What symptoms could suggest myositis occurring with myocarditis?
In people receiving an immune checkpoint inhibitor, new drooping eyelids, double vision, trouble swallowing, neck weakness, or breathing weakness may signal inflammation affecting muscles or nerves in addition to the heart. These symptoms can be serious and should prompt immediate emergency evaluation.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Given my diagnosis, which specific 'red flag' symptoms should trigger a call to your office versus a 911 call?
  2. 2.My ejection fraction is currently normal—does this mean my risk for rhythm issues like heart block is lower, or do we still need to monitor for it?
  3. 3.What did my latest troponin and NT-proBNP levels show, and what 'trend' are we looking for in these numbers?
  4. 4.Are there specific signs of muscle weakness or 'myositis' I should look for that might signal my myocarditis is part of a larger immune flare-up?
  5. 5.How often should I be getting follow-up ECGs or rhythm monitoring to check for 'silent' electrical changes?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (19)
  1. 1

    Smoldering myocarditis following immune checkpoint blockade.

    Norwood TG, Westbrook BC, Johnson DB, et al.

    Journal for immunotherapy of cancer 2017; (5(1)):91 doi:10.1186/s40425-017-0296-4.

    PMID: 29157297
  2. 2

    A retrospective study of immune checkpoint inhibitor-associated myocarditis in a single center in China.

    Wang F, Sun X, Qin S, et al.

    Chinese clinical oncology 2020; (9(2)):16 doi:10.21037/cco.2020.03.08.

    PMID: 32279526
  3. 3

    A closer look at immune-mediated myocarditis in the era of combined checkpoint blockade and targeted therapies.

    Guo CW, Alexander M, Dib Y, et al.

    European journal of cancer (Oxford, England : 1990) 2020; (124()):15-24 doi:10.1016/j.ejca.2019.09.009.

    PMID: 31707280
  4. 4

    Emerging role of immune checkpoint inhibitors and their relevance for the cardiovascular system.

    Michel L, Totzeck M, Lehmann L, Finke D

    Herz 2020; (45(7)):645-651 doi:10.1007/s00059-020-04954-8.

    PMID: 32533218
  5. 5

    Myocarditis in systemic immune-mediated diseases: Prevalence, characteristics and prognosis. A systematic review.

    Cheng CY, Baritussio A, Giordani AS, et al.

    Autoimmunity reviews 2022; (21(4)):103037 doi:10.1016/j.autrev.2022.103037.

    PMID: 34995763
  6. 6

    Update on acute myocarditis.

    Ammirati E, Veronese G, Bottiroli M, et al.

    Trends in cardiovascular medicine 2021; (31(6)):370-379 doi:10.1016/j.tcm.2020.05.008.

    PMID: 32497572
  7. 7

    Myocarditis in Patients Treated With Immune Checkpoint Inhibitors.

    Mahmood SS, Fradley MG, Cohen JV, et al.

    Journal of the American College of Cardiology 2018; (71(16)):1755-1764 doi:10.1016/j.jacc.2018.02.037.

    PMID: 29567210
  8. 8

    Pembrolizumab-induced myocarditis with complete atrioventricular block and concomitant myositis in a metastatic bladder cancer patient: a case report and review of the literature.

    Saad R, Ghaddar A, Zeenny RM

    Journal of medical case reports 2024; (18(1)):107 doi:10.1186/s13256-024-04397-3.

    PMID: 38383436
  9. 9

    Cyclophosphamide-Induced Hemorrhagic Myocarditis.

    Jibawi Rivera RR, Harmon DM, Herrmann J, Pellikka PA

    JACC. Case reports 2026; (31(8)):106613 doi:10.1016/j.jaccas.2025.106613.

    PMID: 41563187
  10. 10

    Electrocardiographic Features of Immune Checkpoint Inhibitor-Associated Myocarditis.

    Song W, Zheng Y, Dong M, et al.

    Current problems in cardiology 2023; (48(2)):101478 doi:10.1016/j.cpcardiol.2022.101478.

    PMID: 36336121
  11. 11

    Immune checkpoint inhibitor sintilimab-induced lethal myocarditis overlapping with myasthenia gravis in thymoma patient: A case report.

    Wang C, Zhong B, He J, Liao X

    Medicine 2023; (102(15)):e33550 doi:10.1097/MD.0000000000033550.

    PMID: 37058040
  12. 12

    PD-1 inhibitors-associated myocarditis in non-small cell lung cancer patients.

    He Y, Chen W, Cai J, et al.

    Journal of thoracic disease 2023; (15(9)):4606-4619 doi:10.21037/jtd-23-596.

    PMID: 37868865
  13. 13

    Clinical Characteristics and Prognostic Factors of Myocarditis in New Zealand Patients.

    Wong BTW, Christiansen JP

    Heart, lung & circulation 2020; (29(8)):1139-1145 doi:10.1016/j.hlc.2020.01.007.

    PMID: 32094080
  14. 14

    The prognostic value of global myocardium strain by CMR-feature tracking in immune checkpoint inhibitor-associated myocarditis.

    Zhao SH, Yun H, Chen CZ, et al.

    European radiology 2022; (32(11)):7657-7667 doi:10.1007/s00330-022-08844-x.

    PMID: 35567603
  15. 15

    Patients with acute myocarditis and preserved systolic left ventricular function: comparison of global and regional longitudinal strain imaging by echocardiography with quantification of late gadolinium enhancement by CMR.

    Meindl C, Paulus M, Poschenrieder F, et al.

    Clinical research in cardiology : official journal of the German Cardiac Society 2021; (110(11)):1792-1800 doi:10.1007/s00392-021-01885-0.

    PMID: 34086089
  16. 16

    Left atrial strain parameters derived by echocardiography are impaired in patients with acute myocarditis and preserved systolic left ventricular function.

    Meindl C, Paulus M, Poschenrieder F, et al.

    The international journal of cardiovascular imaging 2023; (39(6)):1157-1165 doi:10.1007/s10554-023-02827-9.

    PMID: 36961599
  17. 17

    Diagnosis of immune checkpoint inhibitor-associated myocarditis: A systematic review.

    Pradhan R, Nautiyal A, Singh S

    International journal of cardiology 2019; (296()):113-121 doi:10.1016/j.ijcard.2019.07.025.

    PMID: 31327516
  18. 18

    Immune checkpoint Inhibitor-Related Myocarditis: A Comprehensive Analysis of Clinical Manifestations and Prognostic Factors.

    Fan Y, Xu Y, Liu X, et al.

    The oncologist 2025; doi:10.1093/oncolo/oyaf285.

    PMID: 40996334
  19. 19

    Global longitudinal strain by CMR improves prognostic stratification in acute myocarditis presenting with normal LVEF.

    Porcari A, Merlo M, Baggio C, et al.

    European journal of clinical investigation 2022; (52(10)):e13815 doi:10.1111/eci.13815.

    PMID: 35598175

This page is for informational purposes only and does not constitute medical advice. It explains warning signs and monitoring issues in autoimmune myocarditis, but your care team should guide decisions about your specific symptoms and when to seek emergency care.

Get notified when new evidence is published on Autoimmune myocarditis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.